Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma

Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and safety in patients with uncontrolled asthma.We randomly assigned 1902 patients 12 years of age or older with uncontrolled asthma in a...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Castro, M, Corren, J, Pavord, I, Maspero, J, Wenzel, S, Rabe, K, Busse, W, Ford, L, Sher, L, FitzGerald, J, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, N, Hamilton, J, Swanson, B, Stahl, N, Yancopoulos, G, Teper, A
Format:	Journal article
Język:	English
Wydane:	Massachusetts Medical Society 2018

Podobne zapisy

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma
od: Castro, M, i wsp.
Wydane: (2018)

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis
od: Maspero, JF, i wsp.
Wydane: (2019)

Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study
od: Maspero, J, i wsp.
Wydane: (2018)

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma
od: Busse, WW, i wsp.
Wydane: (2018)

Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
od: Pavord, I, i wsp.
Wydane: (2018)

Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study
od: Castro, M, i wsp.
Wydane: (2018)

Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST
od: Wenzel, SE, i wsp.
Wydane: (2018)

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
od: Guilbert TW, i wsp.
Wydane: (2024-03-01)

Azithromycin in uncontrolled asthma
od: Brusselle, G, i wsp.
Wydane: (2017)

Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
od: Eugene R. Bleecker, i wsp.
Wydane: (2023-01-01)

Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
od: Sung-Hee Oh, i wsp.
Wydane: (2024-08-01)

Efficacy of tezepelumab against uncontrolled severe non‐type 2 asthma refractory to bronchial thermoplasty, benralizumab, dupilumab and mepolizumab
od: Yoshiro Kai, i wsp.
Wydane: (2024-03-01)

Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma—A Multidisciplinary Monocentric Real-Life Study
od: Gian Luca Fadda, i wsp.
Wydane: (2025-02-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
od: C. Grote, i wsp.
Wydane: (2025-12-01)

[Translated article] Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
od: B. Roque Quintana, i wsp.
Wydane: (2024-02-01)

Control del prurito refractario en epidermólisis ampollosa pruriginosa con dupilumab
od: B. Roque Quintana, i wsp.
Wydane: (2024-02-01)

Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma
od: Trivedi, A, i wsp.
Wydane: (2016)

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis
od: Mohamed A. Kamal, i wsp.
Wydane: (2024-11-01)

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
od: Christian Domingo, i wsp.
Wydane: (2023-11-01)

Dupilumab for the treatment of pityriasis lichenoides chronica
od: Charissa N. Obeng-Nyarko, MS, i wsp.
Wydane: (2024-08-01)

Successful treatment of Kimura’s disease with dupilumab and review of dupilumab in treating eosinophilic dermatoses
od: Yunhong Zheng, i wsp.
Wydane: (2025-12-01)

Efficacy and Safety of Methylphenidate for ADHD and Uncontrolled Seizures
od: J Gordon Millichap
Wydane: (2011-08-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
od: Nikolay N. Murashkin, i wsp.
Wydane: (2024-11-01)

The Relationship between Mindfulness and Uncontrollability of Ruminative Thinking
od: Raes, F, i wsp.
Wydane: (2010)

The Relationship between Mindfulness and Uncontrollability of Ruminative Thinking
od: Raes, F, i wsp.
Wydane: (2010)

Modern Possibilities of Usage Dupilumab in Children
od: Anna A. Kosova, i wsp.
Wydane: (2024-12-01)

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
od: A. Arrobas, i wsp.
Wydane: (2021-03-01)

Approaches to the treatment of uncontrolled hypertension. Place of the Physiotens®
od: S. N. Tereshchenko, i wsp.
Wydane: (2021-07-01)

Cost‐Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan
od: Kazuomi Kario, i wsp.
Wydane: (2024-12-01)

UNCONTROLLED PHOTOMULTIPLIER CURRENT IN PHOTOEMISSION ANALYSIS
od: K. A. Viazava, i wsp.
Wydane: (2016-09-01)

Granulomatous hyperinflammatory state induced by dupilumab treatment for eosinophilic esophagitis
od: Kanak V. Kennedy, MD, i wsp.
Wydane: (2024-11-01)

MANAGEMENT OF IN-PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION
od: I. V. Logacheva, i wsp.
Wydane: (2014-04-01)

MANAGEMENT OF IN-PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION
od: I. V. Logacheva, i wsp.
Wydane: (2014-04-01)

Dupilumab for Atopic Dermatitis During Pregnancy and Breastfeeding: A Case Report
od: J.M. Alvarenga, i wsp.
Wydane: (2024-11-01)

Recalcitrant Reactive Perforating Collagenosis Successfully Treated with Dupilumab: A Case Report
od: Li J, i wsp.
Wydane: (2024-06-01)

Determinants associated with uncontrolled asthma in Portugal: A national population-based study
od: C. Camarinha, i wsp.
Wydane: (2023-01-01)

Age at Onset of Epilepsy and Effect of Uncontrolled Seizures on Cognitive Outcome
od: J Gordon Millichap
Wydane: (2012-11-01)

Predictors for the Efficacy of 4-Week Dupilumab Treatment in Atopic Dermatitis Patients
od: Yu L, i wsp.
Wydane: (2025-03-01)

Langerhans Cell Histiocytosis Presenting as Uncontrolled Asthma
od: Frederic A. Rawlins, i wsp.
Wydane: (2013-01-01)

Regular snoring is associated with uncontrolled hypertension
od: Bastien Lechat, i wsp.
Wydane: (2024-02-01)